Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > API Partnership

<< Previous

Bullboard Posts

Next >>

Post by WarrantOfficeron Mar 05, 2024 8:56am

143 Views

Post# 35915325

API Partnership

I have been thru the API website. They provide all that is required. The one question that comes to mind......What took so long for Voyageur to partner with them?

P.S> We have seen other partnerships that did not produce any forward traction. Time to earn the credibility required to evolve Voyageur into the planned billion dollar pharma company.

<< Previous

Bullboard Posts

Next >>

Understanding tax loss season and the “Santa Claus rally”